Bill Hall, 71, has been fighting for his life for 38 years. These days, he’s feeling worn out.
Subcutaneous Ocrelizumab Not Inferior to IV Infusion
MILAN — An investigational 10-minute subcutaneous injection of ocrelizumab (Ocrevus) was non-inferior to the established IV infusion formulation of the drug in multiple sclerosis (MS),
October 15, 2023